发明名称 NOVEL GLP-1 RECEPTOR STABILIZER AND MODULATOR
摘要 PROBLEM TO BE SOLVED: To provide novel GLP-1 receptor stabilizers and modulators.SOLUTION: There are provided compounds that bind the glucagon-like peptide 1 (GLP-1) receptor, methods of their synthesis, methods of their therapeutic and/or prophylactic use, and methods of their use in stabilizing GLP-1 receptor in vitro for crystallization of the GLP-1 receptor. Certain compounds may have activity as modulators or potentiators with respect to glucagon receptor, GIP receptor, GLP-1 and GLP-2 receptors, and PTH receptor on their own or in the presence of receptor ligands such as GIP(1-42), PTH(1-34), Glucagon(1-29), GLP-2(1-33), GLP-1(7-36), GLP-1(9-36), oxyntomodulin and exendin variants.SELECTED DRAWING: None
申请公布号 JP2016128509(A) 申请公布日期 2016.07.14
申请号 JP20160061862 申请日期 2016.03.25
申请人 RECEPTOS INC 发明人 MARCUS F BOEHM;ESTHER MARTINBOROUGH;MANISHA MOORJANI;TAMIYA JUNKO;HUANG LIMING;THOMAS FOWLER;ANDREW NOVAK;PREMJI MEGHANI;ENUGURTHI BRAHMACHARY;ADAM RICHARD YEAGER
分类号 C07C237/42;A61K31/165;A61K31/235;A61K31/341;A61K31/343;A61K31/351;A61K31/36;A61K31/37;A61K31/381;A61K31/404;A61K31/41;A61K31/415;A61K31/4196;A61K31/42;A61K31/421;A61K31/423;A61K31/4245;A61K31/426;A61K31/428;A61K31/44;A61K31/4406;A61K31/4409;A61K31/4439;A61K31/4458;A61K31/4462;A61K31/4465;A61K31/454;A61K31/47;A61K31/472;A61K31/4725;A61K31/495;A61K31/498;A61K31/505;A61K31/517;A61K31/5377;A61K31/54;A61P3/00;A61P3/04;A61P3/10;A61P25/00;A61P43/00;C07C229/14;C07C233/51;C07C233/83;C07C235/56;C07C237/22;C07C237/36;C07C255/57;C07C271/28;C07C311/08;C07C317/40;C07C317/44;C07C323/62;C07D209/08;C07D211/34;C07D213/79;C07D213/80;C07D213/81;C07D213/82;C07D215/48;C07D217/04;C07D231/12;C07D239/26;C07D239/74;C07D241/42;C07D241/44;C07D249/08;C07D257/04;C07D261/18;C07D263/32;C07D263/34;C07D263/56;C07D263/57;C07D271/06;C07D271/10;C07D277/56;C07D277/64;C07D295/15;C07D295/155;C07D295/20;C07D307/24;C07D307/54;C07D307/56;C07D307/78;C07D309/06;C07D309/08;C07D311/16;C07D317/68;C07D333/38;C07D413/04;C07D413/12 主分类号 C07C237/42
代理机构 代理人
主权项
地址